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Introduction
Programmed cell death plays crucial role in many
physiological processes from fetal development and in
adult tissues. Apoptosis is strictly regulated through
many molecular mechanisms, including proteolytic
enzymes such as cathepsin D (CTSD). Cathepsin D is
a glycoprotein, member of A1 family of aspartyl pro-
teases. To A1 family of aspartyl proteases belong most
of aspartyl endopeptidases å resent in human body e.g.
cathepsin E, pepsin A or renin. Aspartyl proteases
hydrolyze peptic bond inside polypeptide chains. In
physiology, cathepsin D is localized inside lysosomal
compartment. Beside catalytic functions, new function
of this protease are recently described i.e. regulation of
programmed cell death. This function is expressed on
various steps of apoptotic pathways. In this short
review we will concentrate on regulation of certain
apoptotic processes by cathepsin D. 
Cathepsin D (EC 3.4.23.5)
The gene of human cathepsin D is located on short arm
of chromosome 11 in region p15 in vicinity of H-ras
oncogene [1,2,11]. Overexpression of CTSD gene
leads to increased synthesis of proenzyme, overloads
transport pathways to lysosomes and is observed as
extracellular secretion of procathepsin D [4,14].
Human cathepsin D consists of 412 aminoacidic
residues, with pre-part that is 20 aminoacids long and
pro-part that is 44 aminoacids long [8]. During its cell
life cathepsin D undergoes various proteolytic trans-
formations. However, postranslational glycosylation is
observed only in cathepsin D, cathepsin E and
memapsin [36]. Other aspartyl proteases does not pres-
ent sugar moieties. 
Sugar moiety is consist of two oligosaccharide
chains connected by N-glycosyde bond with protein
element [5,6]. Terminal mannose residues are phos-
phorylated to mannose 6-phosphate. Differences in
sugar moiety structure is thought to be responsible for
heterogenity of the enzyme. Cathepsin D is synthe-
sized as preproenzyme, transformed into catalytically
inactive proenzyme. Proteases are necessary for trans-
formation of procathepsin D (52 kDa) into active inter-
mittent form (48 kDa) and mature double-chained
enzyme (34 kDa and 14 kDa). Pro-sequence removed
during maturation of enzyme is described in literature
as propetide or activating peptide. Activating peptide
is usually 40-60 aminoacids long. Clevage of prose-
quence can be also autocatalytic. Detailed studies on
maturation of cathepsin D revelead, that during
autoactivation only, the so-called pseudo-cathepsin D
is produced, containing C-terminal part of activating
peptide connected to mature enzyme [9,36]. Full acti-
vation of cathepsin D can be achieved only through
involvement of other lysosomal peptidases. 
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Important feature of cathepsin D is its selective
localization inside acidic compartments of cell. At
least two mechanisms of localization of cathepsin D to
lysosomes are known. In first mechanism the terminal
end of oligosachcaride is marked with mannose 6-
phosphate and along with appropriate concentration of
mannose 6-phosphate receptor (M6Pr) mature enzyme
is transported from Golgi apparatus into endosomes. In
endosomes acidic milieu causes dissociation of this
complex and released receptor is comes back to Golgi
apparatus [6,10,36]. In second mechanisms that is
independent from M6Pr, procathepsin D interacts with
prosaposines. These two particles form a multipart,
connected through N-terminal part of pseudocathepsin
D (in other words C-terminus of activating peptide),
which is transported to primary lysosomes [36,37,39].
These complexes were also observed extracellulary.
Mammalian cells does not contain known
inhibitors of cathepsin D, excluding its propeptide
detached during activation of the enzyme [17].
According to Shibata et al., the activity of cathepsin D
can be also inhibited through DNA fragments. The
higher melting temperature (Tm) the oligonucleotide
have, the stronger is inhibition of the enzyme [18].
Functions of cathepsin D in cells
Cathepsin D is endopeptidase. It cleaves peptide bonds
preferably in hydrophobic aminoacids. The catalytic
center of cathepsin D consists of two asparaginian acid
residues Asp33 i Asp231 [16]. It cleaves used intracel-
lular proteins and proteins in endosomes.  During lim-
ited proteolysis it activates certain proenzymes, pro-
hormones and precursor of biologically active pep-
tides; it inactivates their active forms [7]. Cathepsin D
inactivates many inhibitors of proteolytic enzymes
[8,9]. It also takes part during mitosis, regeneration,
activation of leukocytes and regulation of vassal wall
permeability. The proteolytic activity of the enzyme is
regulated by various intralysosomal factors such as
pH, products of metabolism, hormones, growth factors
and specific inhibitors [10,11]. Hormones, e.g. estro-
gens and progesterone can regulate the synthesis of
cathepsin D and its receptor mannose 6-phosphate. 
In physiology, only trace amounts of procathepsin
D can be observed. Majority (ca. 90%) is transformed
into intermediate form and then into mature enzyme
[3]. Cathepsin D can be found extracellulary what was
confirmed using specific antibodies [12,13]. To inter-
cellular environment and body fluids cathepsin D is
actively excreted or released from dead cells. After
binding by alpha-2-macroglobuline cathepsin D is
eliminated from blood by mononuclear phagocyting
cells. 
Cathepsin D in apoptosis
On every stage of apoptotic cascade cooperation of
many different proteins is necessary.  Most important
effectory proteins of apoptosis are caspases. The activ-
ity of caspases is strictly regulated by inhibitors of
apoptosis proteins (IAP). Moreover, other groups of
proteins are also responsible for regulation of apopto-
sis at different stages. Main regulator of apoptosis are:
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Fig. 1. Involvement of cathepsin D (CTSD) in apoptosis regulation. Solid line presents induction of process; broken line represents efflux
of enzymes (e.g. cathepsin D from lysosomes, cytochrome c from mitochondrion). Abbreviations used: CTSD, cathepsin D; CytC,
cytochrome c; CASP, caspases; Apaf-1, apoptotic protease activating factor-1; TRADD, tumor necrosis factor receptor-associated death
domain; FADD, Fas-associated death domain, Bid, Bcl-2-interacting protein; tBid, truncated Bid; IAPIAP, inhibitors of apoptosis pro-
teins; DFF40, caspase-activated DNase/DNA fragmentation factor; DFF45, inhibitor of caspase-activated DNase. Figure modified basing
on open source KEGG database apoptosis pathway (http://www.genome.jp/kegg/pathway/hsa/hsa04210.html).
Bcl-2 protein family, TNF and p53 [40]. Deiss et al.
presented for the first time that aspartyl protease
cathepsin D is also involved in regulation of apoptosis
[24,25].
Depending on environment cathepsin D can induce
or inhibit apoptosis, acting through different mecha-
nisms. CTSD-mediated apoptosis can be induced by
cytotoxic factors [24-34,38] or prevent apoptosis,
which was discussed in animal models [19-23]. 
Cathepsin D and inducing of apoptosis
Since mid-nineties regulatory role of cathepsin D in
inducing apoptotic pathways is indispensible
[24,25]. Apoptosis is most frequent cause of death of
immunologic cells. This process can be initiated by
two major pathways: intrinsic and extrinsic. Extrinsic
pathway begins at surface of the cell by connection of
appropriate ligand with surface receptor and that
leads to activation of caspase-8, -10 and -3 [41]. Acti-
vation of capase-3 as terminal effector of apoptosis
can be enhanced by additional activation of caspase-
9 and -3 through intrinsic pathway [42]. Intrisinc
pathway is initiated by dysfunction of mitochondri-
ons, which leads to release of caspase activators (e.g.
cytochrome c) and that leads to activation of caspase-
9 and in consequence caspase-3. Both pathways
combine when caspase-8 induces proteolysis of Bid
to truncated Bid (tBid). tBid is transported through
mitochondrion membrane where it augments
oligomerization of Bax and induces intrinsic pathway
of apoptosis [43].
Mature form (34 kDa) of cathepsin D regulates
intrinsic apoptosis pathway through stimulation of
cytochrome c (CytC) release form mitochondrion [27-
29,30,32,34]. Heinrich et al. presented that Bid is
cleaved in vitro at pH=6.2 [38] and that Bax can be
activated independently from Bid cleavage [45]. Pep-
statine A, an in vitro cathepsin D inhibitor, restrains
apoptosis induced by cathepsin D and reactive oxygen
species (ROS) [27-29]. Many anti-tumor chemothera-
peutics can induce apoptosis through cathepsin D i.e.
adriamycine, etoposide, cisplatin and 5-fluorouracil
[27-29,30,32,34]. Erdal et al. examined the effect of
twenty different drugs on inducing apoptosis in tumor
cells [44]. They concluded that seven of examined
agents induced apoptosis through activation of p53
and increased lysosome membrane permeabilization
(LMP). Only three drugs (NSC651079, NSC687852,
gold Cl-3-ethylphosphosine) induced DNA damage
that lead to apoptosis and LMP, but LMP was observed
before DNA was damaged. The decrease of cytosol pH
essential for cathepsin D activation was a consequence
of LMP and lysosomal proton efflux, what was con-
firmed in a study in U937 cell lines treated with TNF-
alpha [48,51].  
The activation of cathepsin D can be also regulated
through sphingolipids, sphingosine and ceramide,
which are produced during hydrolysis of sphingomye-
line by acidic sphingomyelinase (A-SMase)
[27,38,46]. Produced during that type of activation
byceramide cathepsin D, hydrolyses procapsase-9 and
procaspase-3 into their active forms caspase-9 and -3
[38]. Cathepsin D is then a missing link between apop-
tosis induced by ceramide production during TNF
stimulation and apoptotic effectors caspase-9 and 3
[38]. Baumgartner et al. presented an alternative,
CTSD-independent pathway of capase-9 activation
[47]. In cases when induction of apoptosis through
activation of procaspase-8 is not possible, lysosomes
are activated and cathepsin D is released into cytosol.
The reversal situation is also possible, in cases when
activation of lysosomes is inhibited [48,49]. Kashkar
et al. observed that conformational change of Bax can
be independent on its activation by caspase 8 or
cathepsin D - A-SMase can be the sole activator [50].
Inhibition of apoptosis by cathepsin D
Koike et al. observed that neurons of cathepsin D defi-
cient mice accumulate subunit c of mitochondrial ATP
synthase and saposine in lysosomes [20]. Neurons
without cathepsin D presented similar features to those
observed in neuronal ceroid lipofuscinosis. In these
animals atrophy of cells in internal and external
nuclear layer of retina was also observed. The atrophy
of retina  was caused by apoptosis through activation
of caspase-9 and -3 [22]. Similar changes were not
observed in retinas of cathepsin B and L deficient
mice. Stfitg et al. in the series of studies showed that
cathepsin D is indispensable for normal development
of mucus membrane of jejunum in newborn mice
[19,21]. In newborns of cathepsin D knockout mice
(CTSD-/-) normal growth was observed until second
week of life. Since third week loss of weight was
observed.  In 26 day of live newborns died in state of
anorexia. In small intestine walls massive necrosis of
cells was present with creation of thrombembolia in
small vessels of intestine and small coronary arteries.
Berchem et al. observed that 3Y1-Ad12 cell lines
transfected with cathepsin D gene showed overexpres-
sion of CTSD, which can prevent apoptosis independ-
ently from catalytic function of cathepsin D [35].
However the same tumor cells treated with antitumor
agent undergo apoptosis also separately from catalytic
function of cathepsin D [23].
Conclusion
Cathepsin D plays various function in cells which are
not fully recognized yet. Recent publications indicate
that CTSD plays important role in apoptosis. Many
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question concerning transduction of apoptotic signal are
yet to be answered. From evolutional point of view
presence of different way of inducing apoptosis should
protect cells from cancerous transformation. This can
explain relatively low prevalence of cancer considering
very high number of mutations and cell division errors
during life of every organism. Increasing knowledge of
caspase-independent apoptotic pathways can bring vital
clues for designing novel antitumor therapies, in which
proteolytic enzymes will be the target (52).
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